Summary
Elevance Health, Inc. (then WellPoint, Inc.) filed this Form 8-K on April 2, 2007, to disclose information regarding upcoming meetings with securities analysts and investors. The primary purpose of these meetings, scheduled between April 3 and April 10, 2007, was to reaffirm the company's ability to meet previously issued earnings expectations. These expectations were initially communicated through a press release and conference call on January 24, 2007. Investors and analysts were informed that WellPoint's management anticipated confirming its performance against these targets during the upcoming engagements. This filing serves as a standard Regulation FD disclosure, ensuring that material information is broadly disseminated to the public.
Key Highlights
- 1Company (then WellPoint, Inc.) scheduled meetings with securities analysts and investors from April 3 to April 10, 2007.
- 2The purpose of these meetings was to confirm the company's ability to meet prior earnings expectations.
- 3Earnings expectations were previously established on January 24, 2007, via a press release and conference call.
- 4This filing is a Regulation FD disclosure to ensure broad dissemination of information.
- 5Information furnished in this report is not considered 'filed' for Section 18 purposes and will not be incorporated into future filings.
- 6Angela F. Braly, Executive Vice President, General Counsel and Chief Public Affairs Officer, signed the report.